FDA Approved: RYLAZE — Original Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved RYLAZE (ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN) in an original application. It is indicated for the treatment of acute lymphoblastic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• RYLAZE (ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN)

Snippet

ORIG AP for RYLAZE (ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN)